InvestorsHub Logo

surfgreen

02/19/13 9:45 PM

#82614 RE: Slyder009 #82607

Stocks always trade at multiples of their earning based on forward looking potential earnings

So a more conservative est
95M net revenue divided by O/S 808M
Then use multiples based on the growth stage of the stock
So 20 is conservative for a stock in hyper growth phase like MJNA

So in 2 years the should easily be $2+ if they execute

Now imagine if they get EU or FDA approval for CBD to TX chronic pain or one of 150 other diseases